JPET xPharm- The Comprehensive Pharmacology Reference

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by WEAVER, L. C.
Right arrow Articles by BURCH, G. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by WEAVER, L. C.
Right arrow Articles by BURCH, G. R.
Journal of Pharmacology And Experimental Therapeutics, Vol. 116, Issue 3, 268-272, 1956
Copyright © 1956 by American Society for Pharmacology and Experimental Therapeutics


THE EVALUATION OF TWO HALOGENATED SULFOLANES AND PENTYLENETETRAZOL AS ANTAGONISTS TO PENTOBARBITAL

LAWRENCE C. WEAVER 1, WILLIAM M. ALEXANDER 1, BENEDICT E. ABREU 1, and GEORGE R. BURCH 1

1 Research Department, Pitman-Moore Company, Division of Allied Laboratories, Inc., Indianapolis, Indiana

The analeptic activity of either 3-bromosulfolane or 3-iodosulfolane in pentobarbital depressed mice was equal to or greater than that for Metrazol.

In these mouse experiments the halo-sulfolanes induced analepsis without untoward effects in a wider dose range than Metrazol.

Intragastric administration to dogs of the three stimulants in fixed ratios with pentobarbital (Metrazol 3:1, 3-bromosulfolane 3:1, and 3-iodosulfolane 0.6:1) revealed that: a. all were capable of prolonging life but could not alter the lethality of pentobarbital, b. only the bromosulfolane significantly increased the time that dogs remained standing and prolonged that for the onset of anesthesia; c. emesis was not induced by the Metrazol combination and its incidence was low for the sulfolane combinations; d. convulsions were produced by the three mixtures, however, only with that of the bromosulfolane was the incidence high (50 per cent).

Submitted on September 10, 1955







Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 1956 by the American Society for Pharmacology and Experimental Therapeutics.